Search

Daniel E. Kolker

Examiner (ID: 8774)

Most Active Art Unit
1649
Art Unit(s)
1649, 1646, 1644, 1645
Total Applications
546
Issued Applications
177
Pending Applications
78
Abandoned Applications
291

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7467612 [patent_doc_number] => 20040120891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells' [patent_app_type] => new [patent_app_number] => 10/655756 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11942 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120891.pdf [firstpage_image] =>[orig_patent_app_number] => 10655756 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/655756
Compounds for intracellular delivery of therapeutic moieties to nerve cells Sep 4, 2003 Abandoned
Array ( [id] => 7134667 [patent_doc_number] => 20040043410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Methods for testing for and inhibiting the development of Huntington\'s disease' [patent_app_type] => new [patent_app_number] => 10/654850 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3198 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043410.pdf [firstpage_image] =>[orig_patent_app_number] => 10654850 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/654850
Methods for testing for and inhibiting the development of Huntington's disease Sep 3, 2003 Abandoned
Array ( [id] => 7349313 [patent_doc_number] => 20040047865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Compositions and their uses' [patent_app_type] => new [patent_app_number] => 10/655405 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6530 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047865.pdf [firstpage_image] =>[orig_patent_app_number] => 10655405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/655405
Compositions and their uses Sep 3, 2003 Abandoned
Array ( [id] => 170764 [patent_doc_number] => 07662780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Administering hypocretin to obese individuals' [patent_app_type] => utility [patent_app_number] => 10/526110 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 17817 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662780.pdf [firstpage_image] =>[orig_patent_app_number] => 10526110 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/526110
Administering hypocretin to obese individuals Aug 26, 2003 Issued
09/194619 Methods and compositions for development of drug screening procedures and diagnostic tools Aug 24, 2003 Abandoned
Array ( [id] => 7677187 [patent_doc_number] => 20040152639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy' [patent_app_type] => new [patent_app_number] => 10/639405 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 27369 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152639.pdf [firstpage_image] =>[orig_patent_app_number] => 10639405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/639405
Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy Aug 11, 2003 Abandoned
10/639749 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy Aug 11, 2003 Abandoned
Array ( [id] => 7069447 [patent_doc_number] => 20050244832 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-11-03 [patent_title] => 'Class II cytokine receptor-7' [patent_app_type] => utility [patent_app_number] => 10/636716 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13107 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0244/20050244832.pdf [firstpage_image] =>[orig_patent_app_number] => 10636716 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636716
Class II cytokine receptor-7 Aug 6, 2003 Abandoned
Array ( [id] => 7069447 [patent_doc_number] => 20050244832 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-11-03 [patent_title] => 'Class II cytokine receptor-7' [patent_app_type] => utility [patent_app_number] => 10/636716 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13107 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0244/20050244832.pdf [firstpage_image] =>[orig_patent_app_number] => 10636716 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636716
Class II cytokine receptor-7 Aug 6, 2003 Abandoned
Array ( [id] => 7069447 [patent_doc_number] => 20050244832 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-11-03 [patent_title] => 'Class II cytokine receptor-7' [patent_app_type] => utility [patent_app_number] => 10/636716 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13107 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0244/20050244832.pdf [firstpage_image] =>[orig_patent_app_number] => 10636716 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636716
Polynucleotides encoding a class II cytokine receptor Aug 6, 2003 Abandoned
Array ( [id] => 7341398 [patent_doc_number] => 20040191240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Composition and method for nerve regeneration' [patent_app_type] => new [patent_app_number] => 10/633423 [patent_app_country] => US [patent_app_date] => 2003-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 117303 [patent_no_of_claims] => 262 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191240.pdf [firstpage_image] =>[orig_patent_app_number] => 10633423 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/633423
Composition and method for nerve regeneration Jul 30, 2003 Abandoned
Array ( [id] => 7348443 [patent_doc_number] => 20040248252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'DNAs encoding mammalian histamine receptor of the H4 subtype' [patent_app_type] => new [patent_app_number] => 10/626445 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15919 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248252.pdf [firstpage_image] =>[orig_patent_app_number] => 10626445 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/626445
DNAs encoding mammalian histamine receptor of the H4 subtype and encoded protein Jul 22, 2003 Issued
Array ( [id] => 7470822 [patent_doc_number] => 20040096877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 10/624932 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72749 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096877.pdf [firstpage_image] =>[orig_patent_app_number] => 10624932 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/624932
Novel proteins and nucleic acids encoding same Jul 20, 2003 Abandoned
Array ( [id] => 7471068 [patent_doc_number] => 20040096913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Cloning and expression of a new MCP receptor in glial cells' [patent_app_type] => new [patent_app_number] => 10/623472 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9360 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096913.pdf [firstpage_image] =>[orig_patent_app_number] => 10623472 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/623472
Cloning and expression of a new MCP receptor in glial cells Jul 17, 2003 Abandoned
Array ( [id] => 7463706 [patent_doc_number] => 20040101521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Iron sequestration or elimination to reduce neurodegeneration or Parkinsons disease progression' [patent_app_type] => new [patent_app_number] => 10/618444 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14544 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101521.pdf [firstpage_image] =>[orig_patent_app_number] => 10618444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/618444
Iron sequestration or elimination to reduce neurodegeneration or Parkinsons disease progression Jul 10, 2003 Abandoned
Array ( [id] => 7466042 [patent_doc_number] => 20040198658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Stanniocalcin polynucleotides, polypeptides and methods based thereon' [patent_app_type] => new [patent_app_number] => 10/614990 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 88274 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198658.pdf [firstpage_image] =>[orig_patent_app_number] => 10614990 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/614990
Stanniocalcin polynucleotides, polypeptides and methods based thereon Jul 8, 2003 Abandoned
Array ( [id] => 7155766 [patent_doc_number] => 20050026823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues' [patent_app_type] => utility [patent_app_number] => 10/600862 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30322 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026823.pdf [firstpage_image] =>[orig_patent_app_number] => 10600862 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/600862
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues Jun 19, 2003 Abandoned
Array ( [id] => 797903 [patent_doc_number] => 07427489 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-23 [patent_title] => 'Screening assay to identify modulators of the sleep/wake cycle' [patent_app_type] => utility [patent_app_number] => 10/464817 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30446 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427489.pdf [firstpage_image] =>[orig_patent_app_number] => 10464817 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/464817
Screening assay to identify modulators of the sleep/wake cycle Jun 16, 2003 Issued
Array ( [id] => 5726350 [patent_doc_number] => 20060057110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Antigen-presenting cells for neuroprotection and nerve regeneration' [patent_app_type] => utility [patent_app_number] => 10/517666 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16557 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057110.pdf [firstpage_image] =>[orig_patent_app_number] => 10517666 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/517666
Antigen-presenting cells for neuroprotection and nerve regeneration Jun 11, 2003 Abandoned
Array ( [id] => 5814790 [patent_doc_number] => 20060084597 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2006-04-20 [patent_title] => 'USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY' [patent_app_type] => utility [patent_app_number] => 10/518159 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14594 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0084/20060084597.pdf [firstpage_image] =>[orig_patent_app_number] => 10518159 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/518159
Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity Jun 10, 2003 Abandoned
Menu